Phase 1 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are male and aged 18 years or older at the time of signing consent
- People who have a confirmed prostate cancer diagnosis (confirmed through tissue testing) and are scheduled to have their prostate surgically removed within 28 days of the screening visit
- People whose prostate cancer falls within Grade Group 2 to 5 (a measure of how the cancer cells look under a microscope)
- People whose general physical health and ability to carry out daily activities meets a certain minimum level, as assessed using a standard medical scale (confirm with trial site)
- People whose organ function and blood counts are within acceptable ranges at screening
- People who are able to understand and willing to sign a consent form that has been approved by an ethics review board
Who may not be able to join:
- People who have another type of invasive cancer, separate from the prostate cancer being studied
- People for whom doctors expect a drainage tube will need to be used after the prostate removal surgery
- People who have received any other cancer treatment (such as chemotherapy, immunotherapy, radiation, hormone therapy, or similar treatments) within the 28 days before joining the trial
- People who have had allergic reactions to substances with a similar makeup to the ingredients in the study treatment, including poloxamer 407 or sodium hyaluronate
- People who have previously received an organ transplant from another person
- People who have a history of a condition where the immune system does not work properly from birth or early life (primary immunodeficiency)
- People whose heart electrical activity measurement (a specific interval measured on a heart tracing) is above a certain level at screening (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 781-605-8632
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Incidence of dose-limiting toxicities (DLTs) [Safety and Tolerability]; Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.